Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Ocular Melanoma”

169 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 169 results

Large-scale testing (Phase 3)Looking for participantsNCT07015190
What this trial is testing

Neoadjuvant Darovasertib in Primary Uveal Melanoma

Who this might be right for
Uveal Melanoma
IDEAYA Biosciences 520
Not applicableUnknownNCT05889481
What this trial is testing

Morphological, Genetic and Tumour Microenvironment Characterisation in Uveal Melanoma

Who this might be right for
Uveal Melanoma
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 100
Testing effectiveness (Phase 2)Study completedNCT01034787
What this trial is testing

Study of AntiCTLA4 in Patients With Unresectable or Metastatic Uveal Melanoma

Who this might be right for
Uveal Melanoma
AHS Cancer Control Alberta 11
Early research (Phase 1)Active Not RecruitingNCT04328844
What this trial is testing

Assess a PI3Kδ Inhibitor (IOA-244) in Patients With Metastatic Cancers

Who this might be right for
Solid Tumor, AdultNon-Hodgkin Lymphoma, AdultNSCLC+2 more
iOnctura 210
Testing effectiveness (Phase 2)Ended earlyNCT01801358
What this trial is testing

A Phase Ib/II Study of AEB071 and MEK162 in Adult Patients With Metastatic Uveal Melanoma

Who this might be right for
Uveal Melanoma
Array Biopharma, now a wholly owned subsidiary of Pfizer 38
Testing effectiveness (Phase 2)Looking for participantsNCT06070012
What this trial is testing

Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanoma

Who this might be right for
Uveal Melanoma
Diwakar Davar 44
Early research (Phase 1)Ended earlyNCT00002947
What this trial is testing

Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer

Who this might be right for
Brain and Central Nervous System TumorsChildhood Langerhans Cell HistiocytosisGastrointestinal Carcinoid Tumor+9 more
Yale University 35
Not applicableStudy completedNCT00351728
What this trial is testing

Combined PET/CT Imaging for the Early Detection of Ocular Melanoma Metastasis Compared to CT Scanning Alone

Who this might be right for
Ocular MelanomaChoroidal MelanomaUveal Melanoma
Jonsson Comprehensive Cancer Center 174
Early research (Phase 1)Active Not RecruitingNCT05496686
What this trial is testing

Targeted Alpha Particle Radiotherapy for Metastatic Uveal Melanoma

Who this might be right for
Uveal MelanomaMetastatic
Modulation Therapeutics, Inc. 16
Testing effectiveness (Phase 2)Study completedNCT00096083
What this trial is testing

Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Cancer

Who this might be right for
Cancer
Delcath Systems Inc. 56
Testing effectiveness (Phase 2)Study completedNCT01835145
What this trial is testing

Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed by Surgery

Who this might be right for
Recurrent Uveal MelanomaStage III Uveal Melanoma AJCC v7Stage IIIA Uveal Melanoma AJCC v7+3 more
National Cancer Institute (NCI) 47
Early research (Phase 1)Study completedNCT04430842
What this trial is testing

Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S

Who this might be right for
AstrocytomaBrain CancerBrain Metastases+20 more
Quadriga Biosciences, Inc. 15
Large-scale testing (Phase 3)Study completedNCT00324727
What this trial is testing

Hepatic Arterial Infusion With Melphalan Compared With Standard Therapy in Treating Patients With Unresectable Liver Metastases Due to Melanoma

Who this might be right for
Intraocular MelanomaMelanoma (Skin)Metastatic Cancer
Delcath Systems Inc. 93
Early research (Phase 1)Looking for participantsNCT07203391
What this trial is testing

Tebentafusp and Roginolisib in Uveal Melanoma to Prolong T-cell Homeostasis

Who this might be right for
Uveal Melanoma, Metastatic
St Vincent's Hospital, Sydney 8
Early research (Phase 1)Study completedNCT01893099
What this trial is testing

Sorafenib and Radioembolization With Sir-Spheres® for the Treatment of Metastatic Ocular Melanoma

Who this might be right for
Ocular Melanoma
Centre Hospitalier Universitaire Vaudois 11
Early research (Phase 1)Study completedNCT00073944
What this trial is testing

BCX-1777 in Treating Patients With Refractory Cancer

Who this might be right for
Cancer
BioCryst Pharmaceuticals
Not applicableNo Longer AvailableNCT04489433
What this trial is testing

Compassionate Use Program to Access Trametinib and Dabrafenib for Patients With BRAF Mutation-positive Metastatic Melanoma

Who this might be right for
Melanoma
Novartis Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT00244816
What this trial is testing

Taxoprexin® Treatment for Advanced Eye Melanoma

Who this might be right for
Metastatic Melanoma
American Regent, Inc. 22
Testing effectiveness (Phase 2)Study completedNCT00738361
What this trial is testing

Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed By Surgery

Who this might be right for
Intraocular Melanoma
Ohio State University Comprehensive Cancer Center 4
Not applicableLooking for participantsNCT07364474
What this trial is testing

Immune Response to Percutaneous Hepatic Perfusion With Melphalan for Ocular Melanoma Metastatic to the Liver

Who this might be right for
Uveal Melanoma
Massachusetts General Hospital 10
Next Page